The blastic variant (BV) form of mantle cell lymphoma (MCL) is considered to be a very aggressive subtype of non-Hodgkin's lymphoma (NHL). In order to determine its clinico-biological features and… (More)
Despite high-dose therapy and ASCT some patients with aggressive HD fail to achieve long-term survival.
PATIENTS AND METHODS
Forty-three patients with induction failure (n = 19) or very… (More)